Carlos Campoy - Jun 30, 2023 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
6/30/2023, 08:05 PM
Previous filing
Mar 20, 2023
Next filing
Dec 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jun 30, 2023 Common Stock 50K $8.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in 36 equal monthly installments starting one month after grant date of June 30, 2023.